---
kind: "diff"
citation: "S. 581"
bill: "115-s-581"
heading: "Jessie's Law"
from: "is"
from_label: "Introduced in Senate"
to: "es"
to_label: "Engrossed in Senate"
sections_amended: 1
sections_added: 0
sections_removed: 0
url: "https://uscodex.org/bills/115/s/581/changes/es"
---
# S. 581 — what changed
S. 581, Jessie's Law — 1 section amended between Introduced in Senate and Engrossed in Senate.
Edits are marked `struck` and `inserted`.
## Sec. 2 Inclusion of opioid addiction history in patient records
- (a) Best practices—
- (1) In general— Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with appropriate stakeholders, including a patient with a history of opioid use disorder, an expert in electronic health records, an expert in the confidentiality of patient health information and records, and a health care provider, shall identify or facilitate the development of best practices regarding—
- (A) the circumstances under which information that a patient has provided to a health care provider regarding such patient’s history of opioid use disorder should, only at the patient’s request, be prominently displayed in the medical records (including electronic health records) of such patient;
- (B) what constitutes the patient’s request for the purpose described in subparagraph (A); and
- (C) the process and methods by which the information should be so displayed.
- (2) Dissemination— The Secretary shall disseminate the best practices developed under paragraph (1) to health care providers and State agencies.
- (a) Development of standards— Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall develop and disseminate standards to provide information to hospitals and physicians relating to prominently displaying the history of opioid addiction in the medical records (including electronic health records) of any patient who has provided information about such addiction to a health care provider.
- (b) Requirements— The standards developed In identifying or facilitating the development of best practices under subsection (a) (a), as applicable, the Secretary, in consultation with appropriate stakeholders, shall take into account consider the following:
- (1) The potential for addiction relapse or overdose, including overdose death if death, when opioid medications are prescribed to an individual a patient recovering from opioid addiction.use disorder.
- (2) The need to display the past opioid addiction benefits of displaying information about a patient patient’s opioid use disorder history in a manner similar to other potentially lethal medical concerns, including drug allergies and contraindications.
- (3) The need for importance of prominently displaying information about past a patient’s opioid addiction to be prominently displayed use disorder when a physician or medical professional is prescribing medication.medication, including methods for avoiding alert fatigue in providers.
- (4) The need for importance of a variety of appropriate medical professionals, including physicians, nurses, and pharmacists, to have access to information described in this section when prescribing or dispensing opioid medication to ensure that the medication is medically appropriate given the history of addiction of the patient.medication, consistent with Federal and State laws and regulations.
- (5) The importance of protecting patient privacy, including the requirements related to consent for disclosure of substance use disorder information under all applicable laws and regulations.
- (6) All applicable Federal and State laws and regulations.